Funding for this research was provided by:
Canadian Institutes of Health Research (FRN#THC-135235)
Canadian Initiative for Outcomes in Rheumatology Care (N/A)
Text and Data Mining valid from 2019-11-13
Received: 9 July 2019
Revised: 9 September 2019
Accepted: 7 October 2019
First Online: 13 November 2019
Compliance with ethical standards
: This study was reviewed and approved by the University of British Columbia Clinical Research Ethics Board (H14-01465) and Behavioural Research Ethics Board (H16-02061). Written consent was received from all study participants.
: Not applicable.
: HKC reports grants from AstraZeneca and consulting fees from Takeda, Selecta, and Horizon outside of the submitted work.The other authors have disclosed no conflicts of interest.